FIELD: chemistry.
SUBSTANCE: invention reveals how to procure polypeptide forms in a solid state, in which the polypeptide is stabilised against degradation under physiological conditions or conditions that go beyond the limits for a long period of time. Stabilised polypeptide particles, which contain a polypeptide chosen from a super family polypeptide, which activates adenylate cyclase of the hypophysis/glucagons, and a stabilising agent chosen from disaccharides and monosaccharides, which are stable at a chosen acidic pH value, in this case the particles are made from a water solution, which has a chosen acidic pH value and are stable at temperatures till 60°C for a period of at least two months. The solid polypeptide particles under this particular invention provide stabilisation of the polypeptide, allowing them to achieve 96% restoration of the stabilised polypeptide after storage.
EFFECT: development of an effective way of getting stabilised polypeptide form in a solid state.
11 cl, 7 ex, 9 dwg, 8 tbl
Title | Year | Author | Number |
---|---|---|---|
STABLE AQUEOUS PROTEIN COMPOSITIONS OF MIA/CD-RAP | 2011 |
|
RU2739078C2 |
PHARMACEUTICAL COMPOSITION CONTAINING PLASMINOGEN, AND USE THEREOF | 2015 |
|
RU2711989C2 |
STABLE AQUEOUS COMPOSITIONS OF PROTEIN MIA/CD-RAP | 2011 |
|
RU2588658C2 |
COMPOSITION OF NEUREGULIN PREPARATION | 2014 |
|
RU2738158C2 |
COMPOSITIONS BASED ON BISPECIFIC ANTIBODIES TO IL-4/IL-13 | 2014 |
|
RU2690850C2 |
ANTIBODY COMPOSITIONS | 2010 |
|
RU2548772C2 |
LIQUID COMPOSITION OF POLYPEPTIDES CONTAINING FC DOMAIN OF IMMUNOGLOBULIN | 2011 |
|
RU2600847C2 |
PROTEIN STABILISATION FORMULATION FREE FROM MAMMALIAN EXCIPIENTS | 2010 |
|
RU2539388C2 |
METHOD OF STABILIZATION OF POLYPEPTIDE, AND METHODS OF PREPARING POLYPEPTIDE COMPOSITIONS | 1994 |
|
RU2143889C1 |
STABLE COMPOSITIONS OF ANTIBODIES AGAINST PROGRAMMABLE DEATH RECEPTOR OF PD-1 PERSON AND RELATED TREATMENT | 2012 |
|
RU2633509C2 |
Authors
Dates
2008-07-27—Published
2003-10-28—Filed